Beximco Pharmaceuticals Limited (DSE: BXPHARMA)

Beximco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	34,128	65,222	68,969	79,096	28,065	33,864
Market Cap Growth	-20.38%	-5.43%	-12.80%	181.84%	-17.13%	-11.08%
Enterprise Value	43,764	79,259	84,113	87,267	38,810	43,994
Last Close Price	76.50	142.70	147.30	166.19	58.37	69.11
PE Ratio	6.40	13.80	12.83	14.46	7.41	10.16
PS Ratio	0.79	1.66	1.99	2.68	1.10	1.48
PB Ratio	0.73	1.37	1.55	2.12	0.86	1.13
P/FCF Ratio	5.39	17.75	28.75	22.58	8.51	-23.25
P/OCF Ratio	6.20	10.72	13.23	13.13	5.06	11.44
EV/Sales Ratio	1.02	2.02	2.43	2.96	1.52	1.93
EV/EBITDA Ratio	4.58	9.18	10.20	11.70	5.98	7.57
EV/EBIT Ratio	5.64	11.48	12.78	13.75	7.22	9.04
EV/FCF Ratio	6.91	21.57	35.06	24.92	11.76	-30.20
Debt / Equity Ratio	0.15	0.22	0.28	0.20	0.32	0.45
Debt / EBITDA Ratio	0.78	1.21	1.50	1.02	1.62	2.32
Debt / FCF Ratio	1.17	2.89	5.16	2.18	3.18	-9.26
Asset Turnover	0.62	0.58	0.59	0.58	0.52	0.49
Inventory Turnover	1.77	1.77	1.91	2.03	1.91	1.79
Quick Ratio	0.45	0.37	0.35	0.39	0.35	0.34
Current Ratio	1.80	1.57	1.45	1.47	1.15	1.04
Return on Equity (ROE)	10.99%	9.81%	12.19%	14.73%	11.31%	10.63%
Return on Assets (ROA)	6.97%	6.38%	6.95%	7.75%	6.76%	6.55%
Return on Capital (ROIC)	8.37%	7.49%	8.06%	8.98%	7.75%	7.43%
Earnings Yield	15.62%	7.07%	7.43%	6.48%	12.52%	8.96%
FCF Yield	18.57%	5.63%	3.48%	4.43%	11.75%	-4.30%
Dividend Yield	4.58%	2.45%	2.38%	2.11%	2.34%	1.97%
Payout Ratio	29.69%	33.98%	31.68%	11.28%	17.13%	16.66%
Buyback Yield / Dilution	-	-	-	0.00%	-
Total Shareholder Return	4.58%	2.45%	2.38%	2.11%	2.34%	1.97%

Source: S&P Capital IQ. Standard template. Financial Sources.